Listed

Molecular Partners AG: Form 20-F for the period ended Dec 31, 2025

Filed with the SEC on Mar 12, 2026 and accepted by EDGAR at Mar 12, 2026, 16:34 ET.

Share

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2025-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2025-01-01 to 2025-12-31CHF 0ifrs-full:RevenueFromContractsWithCustomers
Operating income12 months2025-01-01 to 2025-12-31−CHF 58.1mifrs-full:ProfitLossFromOperatingActivities
Income tax12 months2025-01-01 to 2025-12-31CHF 2.0kifrs-full:IncomeTaxExpenseContinuingOperations
Net income12 months2025-01-01 to 2025-12-31−CHF 61.7mifrs-full:ProfitLoss
Diluted EPS12 months2025-01-01 to 2025-12-31−CHF 1.65ifrs-full:DilutedEarningsLossPerShare
Basic EPS12 months2025-01-01 to 2025-12-31−CHF 1.65ifrs-full:BasicEarningsLossPerShare
Operating cash flow12 months2025-01-01 to 2025-12-31−CHF 51.3mifrs-full:CashFlowsFromUsedInOperatingActivities
Capital expenditure12 months2025-01-01 to 2025-12-31CHF 714.0kifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
Cash and equivalentsAt period end2025-12-31CHF 82.7mifrs-full:CashAndCashEquivalents
Current assetsAt period end2025-12-31CHF 96.9mifrs-full:CurrentAssets
Total assetsAt period end2025-12-31CHF 102.1mifrs-full:Assets
Current liabilitiesAt period end2025-12-31CHF 11.0mifrs-full:CurrentLiabilities
Total liabilitiesAt period end2025-12-31CHF 21.8mifrs-full:Liabilities
Shareholders' equityAt period end2025-12-31CHF 80.3mifrs-full:Equity
Shares outstandingAt period end2025-12-3140,374,641 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0001745114-26-000009. Last ingested by Listed: Oct 29, 2026, 06:05 ET. Listed shows no prices and gives no investment advice.